Literature DB >> 7976792

Release of eosinophil cationic protein (ECP) in anaphylactoid anaesthetic reactions in vivo and in vitro.

E S Assem1.   

Abstract

In patients with anaphylactoid reactions (AR) to neuromuscular blocking drugs (NMB), eosinophil cationic protein (ECP) was released both in vivo and in vitro, and in IgE-dependent and IgE-independent reactions. Thus, eosinophils may play a role in both types of reactions, and ECP release tests may be of value in the diagnosis and study of the mechanism of AR.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7976792     DOI： 10.1007/BF02007745

Source DB:  PubMed          Journal:  Agents Actions        ISSN： 0065-4299


  7 in total

Review 1.  The eosinophilic leukocyte: structure and function.

Authors:  G J Gleich; C R Adolphson
Journal:  Adv Immunol       Date:  1986       Impact factor: 3.543

2.  Anti-allergic properties of cyclosporin A: inhibition of mediator release from human basophils and rat basophilic leukemia cells (RBL-2H3).

Authors:  C I Ezeamuzie; E S Assem
Journal:  Immunopharmacology       Date:  1990 Jul-Aug

3.  Anaphylactic anaesthetic reactions. The value of paper radioallergosorbent tests for IgE antibodies to muscle relaxants and thiopentone.

Authors:  E S Assem
Journal:  Anaesthesia       Date:  1990-12       Impact factor: 6.955

4.  Predictive value of in vitro tests for the IgE-dependent and the IgE-independent anaphylactoid reactions to muscle relaxants.

Authors:  E S Assem
Journal:  Ann Fr Anesth Reanim       Date:  1993

5.  Mechanisms for eosinophil degranulation; release of the eosinophil cationic protein.

Authors:  I Winqvist; T Olofsson; I Olsson
Journal:  Immunology       Date:  1984-01       Impact factor: 7.397

6.  Biphasic and protracted anaphylaxis.

Authors:  B J Stark; T J Sullivan
Journal:  J Allergy Clin Immunol       Date:  1986-07       Impact factor: 10.793

7.  Radioimmunoassay of human eosinophil cationic protein (ECP) by an improved method. Establishment of normal levels in serum and turnover in vivo.

Authors:  C G Peterson; I Enander; J Nystrand; A S Anderson; L Nilsson; P Venge
Journal:  Clin Exp Allergy       Date:  1991-09       Impact factor: 5.018
  7 in total
  1 in total

Review 1.  Adverse reactions to neuromuscular blocking agents.

Authors:  Paul-Michel Mertes; Marie Claire Laxenaire
Journal:  Curr Allergy Asthma Rep       Date:  2004-01       Impact factor: 4.919
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.